Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
Titel:
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
Auteur:
Choueiri, Toni K Escudier, Bernard Powles, Thomas Tannir, Nizar M Mainwaring, Paul N Rini, Brian I Hammers, Hans J Donskov, Frede Roth, Bruce J Peltola, Katriina Lee, Jae Lyun Heng, Daniel Y C Schmidinger, Manuela Agarwal, Neeraj Sternberg, Cora N McDermott, David F Aftab, Dana T Hessel, Colin Scheffold, Christian Schwab, Gisela Hutson, Thomas E Pal, Sumanta Motzer, Robert J